Towards Healthcare Research & Consulting

UK Cardiovascular Clinical Trials Top Companies and Strategic Involvements

Date : 10 June 2026

Top Companies in the UK Cardiovascular Clinical Trials Market & Their Offerings

UK Cardiovascular Clinical Trials Market Companies are hVIVO, Simbec-Orion, MAC Clinical Research, Richmond Pharmacology, LGC Clinical Diagnostics

Market Ecosystem Analysis

Ecosystem Segment Role in Market Representative Organizations
Technology Providers Clinical trial technologies, EDC, analytics, AI-driven patient recruitment, remote monitoring IQVIA, Medidata Solutions, Oracle Health Sciences
Product Manufacturers Sponsors developing cardiovascular therapeutics and devices AstraZeneca, Novartis, Pfizer, Johnson & Johnson
Service Providers Trial management, monitoring, site management, patient recruitment ICON plc, Parexel, Syneos Health
Platform Providers Clinical data platforms, decentralized trial solutions, RWE platforms IQVIA, Medidata Solutions
CROs/CDMOs End-to-end clinical development support IQVIA, ICON plc, Parexel, Medpace, Worldwide Clinical Trials
Software Vendors CTMS, EDC, ePRO, analytics, patient engagement Veeva Systems, Medidata Solutions, Oracle Health Sciences
Research Institutions Clinical trial execution, translational research, investigator-led studies University of Oxford, Imperial College London, University College London, Queen Mary University of London 
End-User Industries Pharmaceutical, Biotechnology, Medical Device, Diagnostics, Digital Health Global Pharma, Biotech Startups, MedTech Companies, NHS Trusts

What are the Recent Developments in the UK Cardiovascular Clinical Trials Market? 

  • In March 2026, AstraZeneca advanced cardiovascular research by completing a heart failure study that utilized wearable ECG technology for remote patient monitoring. This development highlights the growing adoption of decentralized clinical trials in the UK, supporting more efficient data collection, enhanced patient engagement, and accelerated cardiovascular therapy development.
  • In February 2026, Bristol Myers Squibb collaborated with Evinova to enhance clinical trial operations through AI-powered study design solutions. This initiative reflects the increasing use of advanced technologies in the UK clinical trials landscape, helping improve protocol planning, streamline trial processes, and support more efficient patient-focused research.
Tier 1
Company Name Headquarters Country Why Relevant to This Market Key Products/Services Related to Keyword
IQVIA Durham, North Carolina USA Largest global CRO with extensive cardiovascular trial capabilities and strong UK operations Cardiovascular clinical development, patient recruitment, RWE, data analytics
ICON plc Dublin Ireland Major cardiovascular CRO supporting multinational and UK-based cardiovascular studies Full-service cardiovascular clinical trials
Parexel Durham, North Carolina USA Leading global CRO with cardiovascular therapeutic expertise and regulatory support Clinical operations, cardiovascular trial management
Medpace Cincinnati, Ohio USA Highly specialized cardiovascular and metabolic clinical research provider Cardiovascular Phase I-IV trials
Syneos Health Morrisville, North Carolina USA Significant global cardiovascular development capabilities and UK trial execution Integrated clinical and commercialization services
Tier 2
Company Name Headquarters Country Why Relevant to This Market Key Products/Services Related to Keyword
Worldwide Clinical Trials Research Triangle Park, North Carolina USA Growing cardiovascular and metabolic trial expertise Cardiovascular clinical operations
Charles River Laboratories Wilmington, Massachusetts USA Expanding clinical research and cardiovascular development services Translational and clinical support
Fortrea Durham, North Carolina USA Large CRO with cardiovascular therapeutic area experience Clinical development services
MAC Clinical Research Merseyside, England UK Strong UK patient recruitment and cardiovascular study execution Site management and cardiovascular trials
Thermo Fisher Scientific (PPD Clinical Research) Wilmington, North Carolina USA Extensive global trial infrastructure supporting cardiovascular programs Clinical development and trial management
Tier 3
Company Name Headquarters Country Why Relevant to This Market Key Products/Services Related to Keyword
Sofpromed Madrid Spain Active European CRO supporting cardiovascular studies Clinical monitoring and project management
Caidya Raleigh, North Carolina USA Mid-sized CRO increasingly active in specialty therapeutic studies Global clinical operations
Lindus Health London, England UK Technology-enabled clinical trial execution platform Decentralized cardiovascular trials
hVIVO London, England UK Expanding clinical research infrastructure and patient recruitment capabilities Clinical research services
Veramed Twickenham, England UK Specialized biostatistics and data science support for cardiovascular trials Biometrics and statistical services

Supply Chain Analysis

R&D

  • The UK cardiovascular clinical trials market benefits from the NHS's integrated healthcare system, which provides researchers with access to a large patient population and extensive real-world health data. This supports faster patient recruitment, efficient clinical study execution, and advanced cardiovascular research.
  • Key players: hVIVO, Simbec-Orion, MAC Clinical Research, Richmond Pharmacology, LGC Clinical Diagnostics.

Regulatory Approvals

  • The UK cardiovascular clinical trials market is supported by a well-structured regulatory framework, where clinical studies undergo review by both regulatory and ethics authorities through a unified application process. This streamlined approach helps improve trial efficiency, maintain patient safety, and accelerate research activities.
  • Key players: hVIVO, Simbec-Orion, MAC Clinical Research, Richmond Pharmacology, LGC Clinical Diagnostics.

Patient Support and Services

  • The UK cardiovascular clinical trials market is strengthened by strong patient support networks and collaborative research organizations that help improve trial participation, study design, and patient engagement. These efforts contribute to better patient outcomes, high-quality data collection, and more effective cardiovascular research.
  • Key players: hVIVO, Simbec-Orion, MAC Clinical Research, Richmond Pharmacology, and LGC Clinical Diagnostics.